Related Experiment Video

Updated: May 11, 2026

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

1.4K

Advancing the Treatment Paradigm for Multivessel Coronary Artery Disease: Hybrid Coronary Revascularization

Parth M Patel1, Ryon L Arrington1, Amalia Jonsson1

  • 1Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA.

Innovations (Philadelphia, Pa.)
|February 3, 2025
PubMed

Insights

Hybrid coronary revascularization (HCR) is a safe and effective minimally invasive option for multivessel coronary artery disease (CAD). Complete revascularization with HCR improves long-term survival, while incomplete procedures are linked to poorer outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Medical Technology

Background:

  • Multivessel coronary artery disease (CAD) poses significant treatment challenges.
  • Conventional treatments like coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) have limitations.
  • Hybrid coronary revascularization (HCR) combines surgical and interventional techniques.

Purpose of the Study:

  • To evaluate the long-term safety and efficacy of HCR.
  • To assess HCR outcomes in a large cohort of patients with multivessel CAD.
  • To identify risk factors for adverse events after HCR.

Main Methods:

  • A cohort of 561 patients with 2- or 3-vessel CAD underwent planned HCR between 2009 and 2020.
  • HCR involved robot-assisted off-pump LIMA-LAD CABG and PCI of non-LAD vessels.
  • Multivariable regression analysis identified risk factors for short- and long-term outcomes.

Main Results:

  • Low operative mortality (0.7%) and stroke rates (0.9%).
  • High LIMA patency (98%) and low repeat revascularization rates (8% at median 4.5 years).
  • Complete revascularization was associated with significantly better 5-year survival (91% vs. 64%).

Conclusions:

  • HCR is a safe and effective minimally invasive alternative for selected patients with multivessel CAD.
  • Low rates of repeat revascularization and mortality are observed.
  • Incomplete revascularization is a significant risk factor for reduced long-term survival.
Abstract

Keywords:
coronary artery bypass graftingcoronary artery diseasehybrid coronary revascularizationpercutaneous coronary intervention

More Related Videos

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions06:18

Author Spotlight: Segmentation and VR for Advanced Neurovascular Interventions

Published on: April 5, 2024

937
Novel and Innovative Hybrid Technique for Type A Aortic Dissection06:26

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

186

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...